PRESTIGE CONSMR (PBH)
(Delayed Data from NYSE)
$73.53 USD
-0.02 (-0.03%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $73.51 -0.02 (-0.03%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for Prestige Consumer Healthcare Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 46 | 58 | 27 | 32 | 95 |
Receivables | 177 | 167 | 139 | 115 | 151 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 139 | 162 | 120 | 115 | 116 |
Other Current Assets | 13 | 4 | 6 | 8 | 4 |
Total Current Assets | 375 | 392 | 293 | 270 | 366 |
Net Property & Equipment | 77 | 70 | 71 | 70 | 56 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2,848 | 2,869 | 3,276 | 3,054 | 3,055 |
Deposits & Other Assets | 6 | 3 | 3 | 3 | 3 |
Total Assets | 3,318 | 3,354 | 3,671 | 3,429 | 3,514 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 39 | 63 | 56 | 46 | 62 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 1 | 3 | 3 | 3 | 1 |
Accrued Expenses | 72 | 88 | 79 | 68 | 81 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 117 | 161 | 143 | 122 | 150 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 404 | 380 | 445 | 434 | 408 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,126 | 1,346 | 1,477 | 1,480 | 1,730 |
Non-Current Capital Leases | 0 | 2 | 5 | 7 | 5 |
Other Non-Current Liabilities | 9 | 8 | 7 | 9 | 25 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,663 | 1,907 | 2,093 | 2,071 | 2,343 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 567 | 535 | 516 | 500 | 488 |
Retained Earnings | 1,341 | 1,132 | 1,214 | 1,009 | 844 |
Other Equity | -35 | -32 | -19 | -20 | -44 |
Treasury Stock | 220 | 189 | 134 | 131 | 118 |
Total Shareholder's Equity | 1,655 | 1,447 | 1,578 | 1,358 | 1,171 |
Total Liabilities & Shareholder's Equity | 3,318 | 3,354 | 3,671 | 3,429 | 3,514 |
Total Common Equity | 1,655 | 1,447 | 1,578 | 1,358 | 1,171 |
Shares Outstanding | 49.60 | 49.60 | 50.20 | 49.80 | 50.20 |
Book Value Per Share | 33.37 | 29.18 | 31.43 | 27.28 | 23.33 |
Fiscal Year End for Prestige Consumer Healthcare Inc falls in the month of March.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 34 | 46 | 64 | 60 | 55 |
Receivables | 172 | 177 | 174 | 158 | 158 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 152 | 139 | 149 | 161 | 170 |
Other Current Assets | 11 | 13 | 7 | 8 | 9 |
Total Current Assets | 369 | 375 | 394 | 388 | 392 |
Net Property & Equipment | 75 | 77 | 70 | 71 | 70 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2,846 | 2,848 | 2,856 | 2,855 | 2,864 |
Deposits & Other Assets | 6 | 6 | 6 | 4 | 3 |
Total Assets | 3,308 | 3,318 | 3,340 | 3,333 | 3,346 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 40 | 39 | 39 | 44 | 58 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 1 | 1 | 2 | 3 | 3 |
Accrued Expenses | 70 | 72 | 80 | 76 | 80 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 114 | 117 | 127 | 130 | 147 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 409 | 404 | 397 | 388 | 384 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,091 | 1,126 | 1,199 | 1,263 | 1,317 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 1 |
Other Non-Current Liabilities | 5 | 9 | 9 | 8 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1,627 | 1,663 | 1,739 | 1,797 | 1,865 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 573 | 567 | 556 | 552 | 547 |
Retained Earnings | 1,390 | 1,341 | 1,292 | 1,239 | 1,185 |
Other Equity | -31 | -35 | -29 | -36 | -32 |
Treasury Stock | 252 | 220 | 220 | 220 | 220 |
Total Shareholder's Equity | 1,681 | 1,655 | 1,601 | 1,536 | 1,480 |
Total Liabilities & Shareholder's Equity | 3,308 | 3,318 | 3,340 | 3,333 | 3,346 |
Total Common Equity | 1,681 | 1,655 | 1,601 | 1,536 | 1,480 |
Shares Outstanding | 49.60 | 49.60 | 49.60 | 49.60 | 49.50 |
Book Value Per Share | 33.89 | 33.37 | 32.27 | 30.97 | 29.91 |